146940-58-1

Basic information

• Product Name: Ethyl 6-<2-(formyl)phenoxy>hexanoate
• Synonyms: Ethyl 6-<2-(formyl)phenoxy>hexanoate
• CAS NO: 146940-58-1
• Molecular Weight: 264.321
• Mol File: 146940-58-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Ethyl 6-<2-(formyl)phenoxy>hexanoate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 6-<2-(formyl)phenoxy>hexanoate(146940-58-1)
• EPA Substance Registry System: Ethyl 6-<2-(formyl)phenoxy>hexanoate(146940-58-1)

Safety Data

• Hazardous Substances Data: 146940-58-1(Hazardous Substances Data)

Upstream product

• 25542-62-5 6-bromo-hexanoic acid ethyl ester 
• 90-02-8 salicylaldehyde 

Downstream Products

• 147452-31-1 6-<2-<<(Aminoiminomethyl)hydrazono>methyl>phenoxy>hexanoic acid hemisulfate 
• 146910-04-5 6-<2-<<(4,5-Dihydro-1H-imidazol-2-yl)hydrazono>methyl>phenoxy>hexanoic acid hydrobromide 
• 344872-52-2 6-<2-(1,3-Dioxolan-2-yl)phenoxy>hexansaeure-ethylester 
• 88018-03-5 (2E)-8-(2-Formylphenoxy)-2-octensaeure-methylester 
• 344762-88-5 2-<2-(6-Hydroxyhexyloxy)phenyl>-1,3-dioxolan 
• 344762-89-6 6-<2-(1,3-Dioxolan-2-yl)phenoxy>hexanal 
• 1390665-74-3 C₃₂H₃₇NO₆ 
• 1390666-02-0 C₂₅H₃₂BrNO₄ 
• 1390665-77-6 ethyl 6-(2-((4-bromo-N-isopropylbenzamido)methyl)phenoxy)hexanoate 
• 1390665-78-7 ethyl 6-(2-((isopropylamino)methyl)phenoxy)hexanoate 
• 1390665-81-2 C₁₈H₂₉NO₃ 
• 1390665-65-2 C₃₀H₃₃NO₆ 
• 1390665-68-5 C₃₀H₃₃NO₆ 

Relevant articles and documents

Synthesis of some guanylhydrazones and imidazolinylhydrazones as thromboxane-synthase and platelet aggregation inhibitors

The imidazolinylhydrazones of (3-pyridinyloxy)-acetaldehyde and of 6-[3(2-formyl-pyridinyl)oxy]hexanoic acid were synthesized as cyclic analogues of the corresponding guanylhydrazones which were found to be selective inhibitors of human thromboxane-syntha

PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

Provided herein are compounds of Formula (I) and compositions useful in increasing PPARS activity. The compounds and compositions provided herein are useful for the treatment of PPARS related diseases (e.g., muscular diseases, vascular disease, demyelinat

Synthesis and structure-activity relationship of disubstituted benzamides as a novel class of antimalarial agents

Malaria is a devastating world health problem. Using a compound library screening approach, we identified a novel series of disubstituted benzamide compounds with significant activity against malaria strains 3D7 and K1. These compounds represent a new antimalarial molecular scaffold exemplified by compound 1, which demonstrated EC50 values of 60 and 430 nM against strains 3D7 and K1, respectively. Herein we report our findings on the efficient synthesis, structure-activity relationships, and biological activity of this new class of antimalarial agents.